Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents
- PMID: 18461146
- PMCID: PMC2330163
- DOI: 10.1371/journal.pone.0002128
Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents
Abstract
Background: Disclosure of authors' financial interests has been proposed as a strategy for protecting the integrity of the biomedical literature. We examined whether authors' financial interests were disclosed consistently in articles on coronary stents published in 2006.
Methodology/principal findings: We searched PubMed for English-language articles published in 2006 that provided evidence or guidance regarding the use of coronary artery stents. We recorded article characteristics, including information about authors' financial disclosures. The main outcome measures were the prevalence, nature, and consistency of financial disclosures. There were 746 articles, 2985 authors, and 135 journals in the database. Eighty-three percent of the articles did not contain disclosure statements for any author (including declarations of no interests). Only 6% of authors had an article with a disclosure statement. In comparisons between articles by the same author, the types of disagreement were as follows: no disclosure statements vs declarations of no interests (64%); specific disclosures vs no disclosure statements (34%); and specific disclosures vs declarations of no interests (2%). Among the 75 authors who disclosed at least 1 relationship with an organization, there were 2 cases (3%) in which the organization was disclosed in every article the author wrote.
Conclusions/significance: In the rare instances when financial interests were disclosed, they were not disclosed consistently, suggesting that there are problems with transparency in an area of the literature that has important implications for patient care. Our findings suggest that the inconsistencies we observed are due to both the policies of journals and the behavior of some authors.
Conflict of interest statement
Similar articles
-
Conflict of interest policies in science and medical journals: editorial practices and author disclosures.Sci Eng Ethics. 2001 Apr;7(2):205-18. doi: 10.1007/s11948-001-0041-7. Sci Eng Ethics. 2001. PMID: 11349360
-
Scientific journals and their authors' financial interests: a pilot study.Psychother Psychosom. 1998 Jul-Oct;67(4-5):194-201. doi: 10.1159/000012281. Psychother Psychosom. 1998. PMID: 9693346
-
Nursing Journal Policies on Disclosure and Management of Conflicts of Interest.J Nurs Scholarsh. 2020 Nov;52(6):680-687. doi: 10.1111/jnu.12605. Epub 2020 Oct 19. J Nurs Scholarsh. 2020. PMID: 33078574
-
Author disclosure of conflict of interest in vascular surgery journals.J Vasc Surg. 2011 Sep;54(3 Suppl):55S-8S. doi: 10.1016/j.jvs.2011.06.019. J Vasc Surg. 2011. PMID: 21872118 Review.
-
Conflicts of interest and disclosures in publications.Clin Gastroenterol Hepatol. 2007 Mar;5(3):268-73. doi: 10.1016/j.cgh.2006.12.031. Clin Gastroenterol Hepatol. 2007. PMID: 17368225 Review. No abstract available.
Cited by
-
"Why Don't You Go Into Suburbs? Why Are You Targeting Us?": Trust and Mistrust in HIV Vaccine Trials in South Africa.J Empir Res Hum Res Ethics. 2018 Dec;13(5):525-536. doi: 10.1177/1556264618804740. J Empir Res Hum Res Ethics. 2018. PMID: 30417754 Free PMC article.
-
Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study.BMJ Open. 2019 Jul 26;9(7):e030750. doi: 10.1136/bmjopen-2019-030750. BMJ Open. 2019. PMID: 31350254 Free PMC article.
-
Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study.BMC Med Ethics. 2012 Sep 26;13:24. doi: 10.1186/1472-6939-13-24. BMC Med Ethics. 2012. PMID: 23013260 Free PMC article.
-
Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?Br J Clin Pharmacol. 2008 Dec;66(6):767-73. doi: 10.1111/j.1365-2125.2008.03272.x. Epub 2008 Jul 31. Br J Clin Pharmacol. 2008. PMID: 18754841 Free PMC article.
-
Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.BMC Health Serv Res. 2016 Aug 15;16(a):383. doi: 10.1186/s12913-016-1646-5. BMC Health Serv Res. 2016. PMID: 27528247 Free PMC article.
References
-
- Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454–465. - PubMed
-
- Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, et al. A national survey of physician-industry relationships. N Engl J Med. 2007;356:1742–1750. - PubMed
-
- Moses H, 3rd, Dorsey ER, Matheson DH, Thier SO. Financial anatomy of biomedical research. JAMA. 2005;294:1333–1342. - PubMed
-
- Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, et al. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry. 2005;162:1957–1960. - PubMed
-
- Schulman KA, Seils DM, Timbie JW, Sugarman J, Dame LA, et al. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med. 2002;347:1335–1341. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources